Protease targeted COVID-19 drug discovery and its challenges: Insight into viral main protease (Mpro) and papain-like protease (PLpro) inhibitors

Ítems similars

• Chemical-informatics approach to COVID-19 drug discovery: Monte Carlo based QSAR, virtual screening and molecular docking study of some in-house molecules as papain-like protease (PLpro) inhibitors
  per: Amin, Sk. Abdul, et al.
  Publicat: (2020)
• Chemical-informatics approach to COVID-19 drug discovery: Exploration of important fragments and data mining based prediction of some hits from natural origins as main protease (Mpro) inhibitors
  per: Ghosh, Kalyan, et al.
  Publicat: (2021)
• Exploring naphthyl derivatives as SARS-CoV papain-like protease (PLpro) inhibitors and its implications in COVID-19 drug discovery
  per: Amin, Sk. Abdul, et al.
  Publicat: (2021)
• First structure–activity relationship analysis of SARS-CoV-2 virus main protease (Mpro) inhibitors: an endeavor on COVID-19 drug discovery
  per: Amin, Sk. Abdul, et al.
  Publicat: (2021)
• Protease targeted COVID-19 drug discovery: What we have learned from the past SARS-CoV inhibitors?
  per: Amin, Sk Abdul, et al.
  Publicat: (2021)